Organ support & nutrition

Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury

N Engl J MedPublished multicenter, open-label, noninferiority trial

Primary result · Major adverse kidney event (death, dependence on renal-replacement therapy, or a serum creatinine concentration more than 25% above the baseline value)Result — go to the resultAdjusted absolute risk difference 6.28 percentage points 95% CI −1.22 to 13.79

Authors' conclusion

Among critically ill patients with acute kidney injury who had indications for renal-replacement therapy, intermittent hemodialysis as the initial treatment approach was not shown to be noninferior to continuous renal-replacement therapy with respect to major adverse kidney events by day 90 and was associated with higher mortality. (Funded by the French Ministry of Health; ICRAKI ClinicalTrials.gov number, NCT06032884.).

Study context

Population
Critically ill adults with acute kidney injury who had indications for renal-replacement therapyunderwent randomization, 535 patients (260 in the intermittent group and 275 in the continuous group) were included in the intention-to-treat population
Participants
554 adults
Comparison
Intermittent hemodialysis vs Continuous renal-replacement therapy
  • Intermittent hemodialysisn = 272
  • Continuous renal-replacement therapyn = 282reference
Primary endpoint
Major adverse kidney event:
  • Death
  • Dependence on renal-replacement therapy
  • A serum creatinine concentration more than 25% above the baseline value
Follow-up
By day 90
Methodological detailsrandomly assigned, intention-to-treat population
  • Randomly assigned
  • Intention-to-treat population

Primary result

As reported in the abstract

Adjusted absolute risk difference

6.28 percentage points

95% CI −1.22 to 13.79

Events by treatment group

Intermittent hemodialysis vs Continuous renal-replacement therapy
adjusted absolute risk difference 6.28 percentage points (95% CI −1.22 to 13.79)

Further findings

OutcomeIntermittent hemodialysisContinuous renal-replacement therapyHazard ratio (95% CI)
Death · by day 9063.1%53.5%1.30 (1.04–1.63)
Kaplan-Meier mortality estimate at day 9063.3%53.6%

Early stopping

The trial was stopped early after sequential interim analyses showed a sustained signal of higher mortality with intermittent hemodialysis than with continuous renal-replacement therapy

Safety

Hypotension (most common complication potentially related to acute kidney injury or renal-replacement therapy)

Original publication

Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med. Published 14 October 2026. doi:10.1056/nejmoa2608397

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.